Distinct transcriptomes and autocrine cytokines underpin maturation and survival of antibody-secreting cells in systemic lupus erythematosus
Open Access
- 1 March 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple autoantibody types, some of which are produced by long-lived plasma cells (LLPC). Active SLE generates increased circulating antibody-secreting cells (ASC). Here, we examine the phenotypic, molecular, structural, and functional features of ASC in SLE. Relative to post-vaccination ASC in healthy controls, circulating blood ASC from patients with active SLE are enriched with newly generated mature CD19 − CD138 + ASC, similar to bone marrow LLPC. ASC from patients with SLE displayed morphological features of premature maturation and a transcriptome epigenetically initiated in SLE B cells. ASC from patients with SLE exhibited elevated protein levels of CXCR4, CXCR3 and CD138, along with molecular programs that promote survival. Furthermore, they demonstrate autocrine production of APRIL and IL-10, which contributed to their prolonged in vitro survival. Our work provides insight into the mechanisms of generation, expansion, maturation and survival of SLE ASC.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (2P01-AI125180-06)
This publication has 87 references indexed in Scilit:
- Association of Circulating Antibody‐Secreting Cell Maturity With Disease Features in Primary Sjögren's SyndromeArthritis & Rheumatology, 2023
- Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI‐551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary DiseaseArthritis & Rheumatology, 2018
- Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus ErythematosusArthritis & Rheumatology, 2017
- The pattern‐recognition receptor nucleotide‐binding oligomerization domain–containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblastsArthritis & Rheumatism, 2011
- Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosusArthritis & Rheumatism, 2010
- Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosusArthritis & Rheumatism, 2009
- Inhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritisArthritis & Rheumatism, 2007
- Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosusArthritis & Rheumatism, 2004
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosusArthritis & Rheumatism, 2000